Yangyang Yu Selected Research

Yangyang Yu Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 08/2016
4	type 2C Congenital disorder of glycosylation 08/2017 - 01/2014
3	Inflammation (Inflammations) 08/2022 - 01/2018
3	Hypoxia (Hypoxemia) 11/2021 - 04/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 12/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2018
2	Schizophrenia (Dementia Praecox) 01/2020 - 11/2017
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 12/2015
2	Retinoblastoma (Glioblastoma, Retinal) 01/2018 - 07/2017
2	Heart Failure 01/2018 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2018
2	Cardiotoxicity 06/2017 - 01/2016
1	Endometriosis 10/2022
1	Melanoma (Melanoma, Malignant) 09/2022
1	Neutropenia 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Exanthema (Rash) 01/2022
1	Adenocarcinoma 12/2021
1	Reperfusion Injury 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Pain (Aches) 08/2016
1	Hyperalgesia 08/2016
1	Neurogenic Inflammation 08/2016
1	Chronic Pain 08/2016
1	Breast Neoplasms (Breast Cancer) 08/2016
1	Triple Negative Breast Neoplasms 08/2016
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 04/2019 - 06/2016
3	Interleukin-8 (Interleukin 8)IBA 08/2017 - 06/2016
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Toll-Like Receptor 2IBA 01/2020 - 12/2015
2	Messenger RNA (mRNA)IBA 01/2020 - 08/2016
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018 - 07/2017
2	Endothelin A ReceptorIBA 01/2018 - 08/2016
2	anti-IgE antibodiesIBA 01/2018 - 01/2014
2	CytokinesIBA 01/2018 - 12/2015
2	CurcuminIBA 01/2018 - 01/2018
2	Endothelin-1 (Endothelin 1)IBA 01/2018 - 08/2016
1	N-methyladenosineIBA 10/2022
1	Indicators and Reagents (Reagents)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 09/2022
1	LipopolysaccharidesIBA 08/2022
1	apatinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	camrelizumabIBA 01/2022
1	asparaginylendopeptidase (legumain)IBA 11/2021
1	erastinIBA 11/2021
1	ChemokinesIBA 01/2020
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 04/2019
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2019
1	Histones (Histone)IBA 01/2019
1	GuanineIBA 04/2018
1	XanthineIBA 04/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Carbon MonoxideIBA 01/2018
1	lipoteichoic acidIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 07/2017
1	Epithelial Cell Adhesion MoleculeIBA 07/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 06/2017
1	saikosaponin DIBA 06/2017
1	Bupleurum root extractIBA 06/2017
1	CalcineurinIBA 12/2016
1	GoldIBA 10/2016
1	Analgesics (Analgesic Drugs)IBA 08/2016
1	cardamoninIBA 08/2016
1	AnkyrinsIBA 08/2016
1	CationsIBA 08/2016
1	Endothelin B ReceptorIBA 08/2016
1	salvianolic acid AIBA 08/2016
1	B7 AntigensIBA 08/2016
1	LigandsIBA 08/2016
1	AntibodiesIBA 08/2016
1	Substance PIBA 06/2016
1	neferineIBA 01/2016
1	liensinineIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2015
1	Peptidoglycan (Murein)IBA 01/2014

Therapy/Procedure

3	Immunotherapy 12/2021 - 08/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
3	Chemoradiotherapy 01/2021 - 01/2020
2	Neoadjuvant Therapy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 07/2017
1	Perioperative Period 01/2022
1	Precision Medicine 10/2016